We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

507 hedge funds and large institutions have $14.4B invested in Bio-Rad Laboratories Class A in 2021 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 171 increasing their positions, 198 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more call options, than puts

Call options by funds: $76.4M | Put options by funds: $54.5M

16% more capital invested

Capital invested by funds: $12.4B → $14.4B (+$2.01B)

11% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 44

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

0.12% less ownership

Funds ownership: 78.65% → 78.53% (-0.12%)

0% less funds holding

Funds holding: 508 → 507 (-1)

14% less repeat investments, than reductions

Existing positions increased: 171 | Existing positions reduced: 198

Holders
507
Holders Change
-1
Holders Change %
-0.2%
% of All Funds
8.88%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
49
Increased
171
Reduced
198
Closed
44
Calls
$76.4M
Puts
$54.5M
Net Calls
+$21.8M
Net Calls Change
+$60.4M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$244M
2
SSA
Schonfeld Strategic Advisors
New York
+$51.6M
3
SEI Investments
SEI Investments
Pennsylvania
+$50.3M
4
Franklin Resources
Franklin Resources
California
+$48.5M
5
Millennium Management
Millennium Management
New York
+$32.8M

Top Sellers

1
Deutsche Bank
Deutsche Bank
Germany
-$75.2M
2
PCH
Polar Capital Holdings
United Kingdom
-$71.7M
3
BlackRock
BlackRock
New York
-$63.8M
4
HP
Hound Partners
New York
-$46.6M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$42.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.69B -$9.31M -12,433 -0.5%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.44B +$244M +325,532 +20%
BlackRock
3
BlackRock
New York
$1.31B -$63.8M -85,136 -5%
State Street
4
State Street
Massachusetts
$733M +$5.89M +7,864 +0.8%
Brown Advisory
5
Brown Advisory
Maryland
$426M +$1.48M +1,976 +0.3%
AllianceBernstein
6
AllianceBernstein
Tennessee
$408M +$16.9M +22,502 +4%
Marshall Wace
7
Marshall Wace
United Kingdom
$328M +$3.18M +4,245 +1%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$318M +$27.1M +36,170 +9%
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$315M +$27.1M +36,122 +9%
Bank of America
10
Bank of America
North Carolina
$285M -$12.1M -16,129 -4%
Invesco
11
Invesco
Georgia
$277M +$20.2M +27,012 +8%
Wells Fargo
12
Wells Fargo
California
$267M +$9.73M +12,986 +4%
UBS AM
13
UBS AM
Illinois
$267M -$9.42M -12,576 -3%
Westfield Capital Management
14
Westfield Capital Management
Massachusetts
$261M -$42.4M -56,589 -14%
Northern Trust
15
Northern Trust
Illinois
$194M -$10.3M -13,766 -5%
CIP
16
Champlain Investment Partners
Vermont
$187M -$7.9M -10,540 -4%
Franklin Resources
17
Franklin Resources
California
$170M +$48.5M +64,804 +40%
IIP
18
Intermede Investment Partners
United Kingdom
$164M +$24.9M +33,204 +18%
Norges Bank
19
Norges Bank
Norway
$154M -$1.18M -1,571 -0.8%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$151M -$31.3M -41,800 -17%
SSA
21
Schonfeld Strategic Advisors
New York
$138M +$51.6M +68,849 +59%
AQR Capital Management
22
AQR Capital Management
Connecticut
$133M +$8.8M +11,753 +7%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$131M -$1.57M -2,095 -1%
EARNEST Partners
24
EARNEST Partners
Georgia
$128M -$1.69M -2,257 -1%
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$128M +$688K +919 +0.5%
1
2 3 4 5

BIO Hedge Fund Activity: Q3 2021 in Review

507 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2021, worth a combined $14.4B — up 16% from $12.4B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new BIO positions and 44 closed out — a net gain of 5 holders — while 171 added to existing stakes and 198 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $244M. The largest seller was Deutsche Bank, cutting an estimated $75.2M.

  • 507 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2021, down from 508 in Q2 2021.
  • Funds reported $14.4B of Bio-Rad Laboratories Class A stock for Q3 2021, up 16% quarter-over-quarter.
  • 49 funds opened new Bio-Rad Laboratories Class A positions in Q3 2021 and 44 closed out, a net change of +5 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2021 was Fidelity Investments, an estimated $244M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2021 was Deutsche Bank, an estimated $75.2M sold.

Based on aggregated 13F filings for Q3 2021.